Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Abarelix: a promising new treatment option for patients with prostate cancer

June 12, 1998

Nippon Shinyaku discovers new treatment for urinary incontinence

June 12, 1998

PEG-rHuMGDF protects against toxicity of chemo- and radiotherapy in mice

June 12, 1998

CS-834 and R-95867 profiled at recent scientific meeting in Japan

June 12, 1998

ET antagonist protects against ciclosporin-induced nephrotoxicity in rats

June 11, 1998

Combination immunotherapy of renal cell carcinoma: efficacy established in phase II trial

June 11, 1998

Excellent phase III results reported for bropirimine in CIS

June 11, 1998

Vapreotide, RC-3940-II and cetrorelix: novel peptide analogues for treating renal cell carcinoma

June 11, 1998

New and established treatments for BPH reviewed at AUA

June 10, 1998

Efficacy of Ginkgo biloba extract in ED disproved in controlled clinical trial

June 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...